glp 1 disorders Popular GLP-1 weight-loss drugs linked to lower risks of addiction and overdose Glucagon-like peptide-1 receptor: mechanisms and

16 The GLP-1RA liraglutide was found in one study to synergistically improve healing with zinc oxide (ZnO) in nanofibrous dressings while preventing infection and promoting vascularization

Dual-Indication Prescribing Several weight loss medications have FDA-approved indications beyond obesity

Glutathione Promotes skin clarity and reduces hyperpigmentation

Margins should also improve as the industry develops pill formulations

The 2024 ASPS Plastic Surgery Statistics Report shows women remain the driving force of the specialty

Phase 3 TRIUMPH-4 trial The most recent Phase 3 results, announced in December 2025, tested retatrutide in people with obesity and knee osteoarthritis